What stocks does Baroda BNP Paribas Health and Wellness Fund Direct Growth hold?

Baroda BNP Paribas Health and Wellness Fund Direct Growth holds a portfolio of Indian equity stocks disclosed monthly by Baroda BNP Paribas Mutual Fund to AMFI. The complete current holdings with weights and month-over-month changes are available on this page. Data is sourced from official AMFI portfolio disclosures.

Which AMC manages Baroda BNP Paribas Health and Wellness Fund Direct Growth?

Baroda BNP Paribas Health and Wellness Fund Direct Growth is managed by Baroda BNP Paribas Mutual Fund, a SEBI-registered Asset Management Company in India.

What category is Baroda BNP Paribas Health and Wellness Fund Direct Growth?

Baroda BNP Paribas Health and Wellness Fund Direct Growth is classified as a Equity mutual fund under SEBI's mutual fund categorisation framework.

← Baroda BNP Paribas Mutual Fund

Baroda BNP Paribas Health and Wellness Fund Direct Growth

Q: How often is Baroda BNP Paribas Health and Wellness Fund Direct Growth portfolio data updated?

Portfolio holdings for Baroda BNP Paribas Health and Wellness Fund Direct Growth are updated monthly. SEBI mandates all AMCs to disclose their complete portfolio within 10 days of each month end. RightAdvise sources this data directly from official AMFI portfolio disclosures.

Equity Data as of Sep 2026 Comparing Aug 2026 → Sep 2026

Share: WhatsApp X

⌕

Stocks Held

Sep 2026

Equity Holdings

₹473.14 Cr

Equity only, excl. debt & cash

AAUM

₹509.83 Cr

Jul-Sep 2026 · Direct + Regular

Top 5 Weight

36.5%

Moderate

Top 10 Weight

58.4%

Moderate

Changes

1 new · 1 exits

Top Sector

Pharmaceuticals & Biotechnology

73.7% of portfolio

Launch Date

09 Jun 2025

1 years old

AAUM (Average Assets Under Management) of ₹509.83 Cr for Jul-Sep 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.

📋 What Happened This Month Baroda BNP Paribas Health and Wellness Fund Direct Growth made 1 new addition and exited 1 stock this month. The biggest new buy was Narayana Hrudayalaya Limited (Healthcare Services) at 0.97% weight. MedPlus Health Services Limited was the biggest exit (Retailing), which was held at 0.93%. Among existing holdings, Laurus Labs Limited saw the biggest increase — now at 6.09% of the portfolio. AstraZeneca Pharma India Limited was trimmed the most, now at 2.79%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 73.7%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.

How Has the NAV Performed?

1 year history · Baroda BNP Paribas Health and Wellness Fund Direct Growth

-7.68%

-5.97%

+5.61%

+3.25%

Latest NAV

₹10.16

23 Oct 2026

52W High

₹11.15

-9% from High

52W Low

₹9.06

+12% from Low

Rolling Returns

Performance across every possible investment start date.

1Y Rolling Avg

9.6%

+ve in 100% windows

13.6% / 4.3%

Crisis Period Behaviour

"Pre-inception" = fund didn't exist during that period.

2024–25 Tariff

Pre-inception

Rec: N/A

COVID-19 Crash

Pre-inception

Rec: N/A

2022 Rate Hike

Pre-inception

Rec: N/A

2018 IL&FS

Pre-inception

Rec: N/A

NAV Chart ₹10.16 23 Oct 2026

Simple Moving Avg: Click to draw · click again to remove

Baroda BNP Paribas Health and Wellness Fund Direct Growth

Chart shows indexed performance (base = 100). Actual NAV: ₹10.16

Sector Shift Industry allocation month-over-month

Jul 2026 → Aug 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	72.1%	74.6%	▲ +2.5%
Healthcare Services	19.7%	19.5%	▼ -0.2%
Insurance	2.3%	2.9%	▲ +0.6%
Retailing	1.1%	0.9%	▼ -0.2%
IT - Services	1.4%	0.9%	▼ -0.6%

Aug 2026 → Sep 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	74.6%	73.7%	▼ -0.9%
Healthcare Services	19.5%	19.8%	▲ +0.3%
Insurance	2.9%	2.7%	▼ -0.2%
IT - Services	0.9%	0.9%	● +0.1%
Retailing	0.9%	0.0%	▼ -0.9%

🟢

Biggest New Buy

Narayana Hrudayalaya Limited

0.97% weight · Healthcare Services

🔴

Biggest Exit

MedPlus Health Services Limited

0.93% was held · Retailing

↑

Biggest Add

Laurus Labs Limited

+0.43% · now 6.09%

↓

Biggest Trim

AstraZeneca Pharma India Limited

-0.77% · now 2.79%

🤝 Other funds also bought this month

Narayana Hrudayalaya Limited 41 funds

👋 Other funds also exited

MedPlus Health Services Limited 3 funds

What Changed in the Portfolio This Month?

Comparing Aug 2026 → Sep 2026

Aug 2026 → Sep 2026

🟢 1 New Entry 🔴 1 Exit ↑ 14 Increased ↓ 18 Decreased

#	Stock	Sector	Weight (Sep 2026)
1	Narayana Hrudayalaya Limited ₹4.75 Cr	Healthcare Services	0.97%

#	Stock	Sector	Last Weight (Aug 2026)
1	MedPlus Health Services Limited ₹4.71 Cr	Retailing	0.93%

#	Stock	Sector	Aug 2026	Sep 2026	Change
1	Laurus Labs Limited ₹29.70 Cr	Pharmaceuticals & Biotechnology	5.66%	6.09%	+0.43%
2	Symbiotec Pharmalab Limited ₹7.15 Cr	Pharmaceuticals & Biotechnology	1.18%	1.47%	+0.29%
3	Mankind Pharma Limited ₹16.27 Cr	Pharmaceuticals & Biotechnology	3.10%	3.34%	+0.24%
4	Dr. Lal Path Labs Limited ₹16.89 Cr	Healthcare Services	3.24%	3.47%	+0.23%
5	Abbott India Limited ₹12.21 Cr	Pharmaceuticals & Biotechnology	2.29%	2.50%	+0.21%
6	Dr. Reddy's Laboratories Limited ₹6.17 Cr	Pharmaceuticals & Biotechnology	1.14%	1.26%	+0.12%
7	Acutaas Chemicals Ltd ₹11.48 Cr	Pharmaceuticals & Biotechnology	2.24%	2.36%	+0.12%
8	Zydus Lifesciences Limited ₹10.92 Cr	Pharmaceuticals & Biotechnology	2.15%	2.24%	+0.09%
9	Ajanta Pharma Limited ₹7.60 Cr	Pharmaceuticals & Biotechnology	1.49%	1.56%	+0.07%
10	Nephrocare Health Services Ltd ₹6.93 Cr	Healthcare Services	1.35%	1.42%	+0.07%
11	Gland Pharma Limited ₹5.80 Cr	Pharmaceuticals & Biotechnology	1.14%	1.19%	+0.05%
12	Inventurus Knowledge Solutions Limited ₹4.37 Cr	IT - Services	0.85%	0.90%	+0.05%
13	Aurobindo Pharma Limited ₹15.05 Cr	Pharmaceuticals & Biotechnology	3.05%	3.09%	+0.04%
14	Emcure Pharmaceuticals Limited ₹11.66 Cr	Pharmaceuticals & Biotechnology	2.38%	2.39%	+0.01%

#	Stock	Sector	Aug 2026	Sep 2026	Change
1	AstraZeneca Pharma India Limited ₹13.61 Cr	Pharmaceuticals & Biotechnology	3.56%	2.79%	-0.77%
2	Fortis Healthcare Limited ₹19.40 Cr	Healthcare Services	4.50%	3.98%	-0.52%
3	Sun Pharmaceutical Industries Limited ₹41.83 Cr	Pharmaceuticals & Biotechnology	9.01%	8.58%	-0.43%
4	Procter & Gamble Health Limited ₹85.28 L	Pharmaceuticals & Biotechnology	0.57%	0.17%	-0.40%
5	Glenmark Pharmaceuticals Limited ₹15.18 Cr	Pharmaceuticals & Biotechnology	3.42%	3.11%	-0.31%
6	Max Financial Services Limited ₹10.78 Cr	Insurance	2.43%	2.21%	-0.22%
7	Lupin Limited ₹28.22 Cr	Pharmaceuticals & Biotechnology	5.99%	5.79%	-0.20%
8	Divi's Laboratories Limited ₹38.10 Cr	Pharmaceuticals & Biotechnology	8.01%	7.82%	-0.19%
9	Apollo Hospitals Enterprise Limited ₹25.72 Cr	Healthcare Services	5.44%	5.28%	-0.16%
10	Metropolis Healthcare Limited ₹6.50 Cr	Healthcare Services	1.49%	1.33%	-0.16%
11	Torrent Pharmaceuticals Limited ₹38.40 Cr	Pharmaceuticals & Biotechnology	7.99%	7.88%	-0.11%
12	IPCA Laboratories Limited ₹29.87 Cr	Pharmaceuticals & Biotechnology	6.23%	6.13%	-0.10%
13	Aster DM Healthcare Limited ₹10.46 Cr	Healthcare Services	2.23%	2.15%	-0.08%
14	GlaxoSmithKline Pharmaceuticals Limited ₹3.32 Cr	Pharmaceuticals & Biotechnology	0.72%	0.68%	-0.04%
15	Manipal Health Enterprises Ltd ₹6.00 Cr	Healthcare Services	1.27%	1.23%	-0.04%
16	Concord Biotech Limited ₹10.30 Cr	Pharmaceuticals & Biotechnology	2.14%	2.11%	-0.03%
17	Cipla Limited ₹5.38 Cr	Pharmaceuticals & Biotechnology	1.11%	1.10%	-0.01%
18	Life Insurance Corporation Of India ₹2.28 Cr	Insurance	0.48%	0.47%	-0.01%

What Stocks Does This Fund Hold?

33 stocks — Sep 2026

#	Stock	Sector	Weight & Value
1	Sun Pharmaceutical Industries Limited ₹41.83 Cr	Pharmaceuticals & Biotechnology	8.58%
2	Torrent Pharmaceuticals Limited ₹38.40 Cr	Pharmaceuticals & Biotechnology	7.88%
3	Divi's Laboratories Limited ₹38.10 Cr	Pharmaceuticals & Biotechnology	7.82%
4	IPCA Laboratories Limited ₹29.87 Cr	Pharmaceuticals & Biotechnology	6.13%
5	Laurus Labs Limited ₹29.70 Cr	Pharmaceuticals & Biotechnology	6.09%
6	Lupin Limited ₹28.22 Cr	Pharmaceuticals & Biotechnology	5.79%
7	Apollo Hospitals Enterprise Limited ₹25.72 Cr	Healthcare Services	5.28%
8	Fortis Healthcare Limited ₹19.40 Cr	Healthcare Services	3.98%
9	Dr. Lal Path Labs Limited ₹16.89 Cr	Healthcare Services	3.47%
10	Mankind Pharma Limited ₹16.27 Cr	Pharmaceuticals & Biotechnology	3.34%
11	Glenmark Pharmaceuticals Limited ₹15.18 Cr	Pharmaceuticals & Biotechnology	3.11%
12	Aurobindo Pharma Limited ₹15.05 Cr	Pharmaceuticals & Biotechnology	3.09%
13	AstraZeneca Pharma India Limited ₹13.61 Cr	Pharmaceuticals & Biotechnology	2.79%
14	Abbott India Limited ₹12.21 Cr	Pharmaceuticals & Biotechnology	2.50%
15	Emcure Pharmaceuticals Limited ₹11.66 Cr	Pharmaceuticals & Biotechnology	2.39%
16	Acutaas Chemicals Ltd ₹11.48 Cr	Pharmaceuticals & Biotechnology	2.36%
17	Zydus Lifesciences Limited ₹10.92 Cr	Pharmaceuticals & Biotechnology	2.24%
18	Max Financial Services Limited ₹10.78 Cr	Insurance	2.21%
19	Aster DM Healthcare Limited ₹10.46 Cr	Healthcare Services	2.15%
20	Concord Biotech Limited ₹10.30 Cr	Pharmaceuticals & Biotechnology	2.11%
21	Ajanta Pharma Limited ₹7.60 Cr	Pharmaceuticals & Biotechnology	1.56%
22	Symbiotec Pharmalab Limited ₹7.15 Cr	Pharmaceuticals & Biotechnology	1.47%
23	Nephrocare Health Services Ltd ₹6.93 Cr	Healthcare Services	1.42%
24	Metropolis Healthcare Limited ₹6.50 Cr	Healthcare Services	1.33%
25	Dr. Reddy's Laboratories Limited ₹6.17 Cr	Pharmaceuticals & Biotechnology	1.26%
26	Manipal Health Enterprises Ltd ₹6.00 Cr	Healthcare Services	1.23%
27	Gland Pharma Limited ₹5.80 Cr	Pharmaceuticals & Biotechnology	1.19%
28	Cipla Limited ₹5.38 Cr	Pharmaceuticals & Biotechnology	1.10%
29	Narayana Hrudayalaya Limited ₹4.75 Cr	Healthcare Services	0.97%
30	Inventurus Knowledge Solutions Limited ₹4.37 Cr	IT - Services	0.90%
31	GlaxoSmithKline Pharmaceuticals Limited ₹3.32 Cr	Pharmaceuticals & Biotechnology	0.68%
32	Life Insurance Corporation Of India ₹2.28 Cr	Insurance	0.47%
33	Procter & Gamble Health Limited ₹85.28 L	Pharmaceuticals & Biotechnology	0.17%